Advertisement
| bepotastine besilate ophthalmic solution: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film Edward J Holland, Mark J Mannis, W. Barry Lee, 2013-05-17 Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today's best medical and surgical approaches. Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease. Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications. Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery. Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease. Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com. |
| bepotastine besilate ophthalmic solution: Handbook of Emergency Ophthalmology Brit Long, Alex Koyfman, 2018-06-21 This book provides emergency physicians with an easy-to-use guide for diagnosing and treating ophthalmologic conditions in the emergency department. Ophthalmologic complaints are very common, but many emergency physicians are not as confident as they would like to be when evaluating and managing these conditions. This book answers that need by giving step-by-step instructions on how to diagnose and treat common eye conditions, including glaucoma, infections, neuro-ophthalmologic conditions, and trauma. For each disorder, the book discusses presentation/symptoms, physical examination techniques, lab and imaging findings, differential diagnoses, treatment guidelines, and referral suggestions. The text is filled with images that clearly present these common ophthalmologic complaints and conditions and guide the emergency physician to an accurate and swift diagnosis. Handbook of Emergency Ophthalmology is an essential resource for emergency physicians, residents, medical students, nurses, and other healthcare workers who evaluate and manage patients with ophthalmologic conditions. |
| bepotastine besilate ophthalmic solution: Heterocyclic N-Oxides Oleg V. Larionov, 2017-07-12 The series Topics in Heterocyclic Chemistry presents critical reviews on present and future trends in the research of heterocyclic compounds. Overall the scope is to cover topics dealing with all areas within heterocyclic chemistry, both experimental and theoretical, of interest to the general heterocyclic chemistry community. The series consists of topic related volumes edited by renowned editors with contributions of experts in the field. All chapters from Topics in Heterocyclic Chemistry are published Online First with an individual DOI. In references, Topics in Heterocyclic Chemistry is abbreviated as Top Heterocycl Chem and cited as a journal. |
| bepotastine besilate ophthalmic solution: Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition , 2012-01-09 Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Obstructive Lung Diseases. The editors have built Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Obstructive Lung Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| bepotastine besilate ophthalmic solution: Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition , 2012-01-09 Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Conjunctival Diseases in a compact format. The editors have built Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Conjunctival Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| bepotastine besilate ophthalmic solution: Advanced Concepts in Human Immunology: Prospects for Disease Control Pooja Jain, Lishomwa C. Ndhlovu, 2020-08-11 This book highlights information derived primarily from clinical samples, with particular reference to theoretical and scientific aspects of the human immune system. This text will focus on topics that range from host-pathogen interactions in infectious disease to host immune response in cancer, allergic diseases, neuroinflammatory diseases, and autoimmune disorders. The reader will also have a well-rounded understanding of the behavior of the immune system with particular emphasis on the role of immunoproteomics in immunotherapy, neuroprotective immunity for neurodegenerative and neuroinfectious disease, leukemia-associated dendritic cell induction of adaptive immunity dysregulation, and the role of immune checkpoint inhibitors in cancer, infection, as well as neuroinflammation. Taken together, the contents of this book are intended for both clinicians and researchers in academia and industry. |
| bepotastine besilate ophthalmic solution: Itch E. Carstens, Tasuku Akiyama, 2014-02-25 Advances in itch research have elucidated differences between itch and pain but have also blurred the distinction between them. There is a long debate about how somatic sensations including touch, pain, itch, and temperature sensitivity are encoded by the nervous system. Research suggests that each sensory modality is processed along a fixed, direct-line communication system from the skin to the brain. Itch: Mechanisms and Treatment presents a timely update on all aspects of itch research and the clinical treatment of itch that accompanies many dermatological conditions including psoriasis, neuropathic itch, cutaneous t-cells lymphomas, and systemic diseases such as kidney and liver disease and cancer. Composed of contributions from distinguished researchers around the world, the book explores topics such as: Neuropathic itch Peripheral neuronal mechanism of itch The role of PAR-2 in neuroimmune communication and itch Mrgprs as itch receptors The role of interleukin-31 and oncostatin M in itch and neuroimmune communication Spinal coding of itch and pain Spinal microcircuits and the regulation of itch Examining new findings on cellular and molecular mechanisms, the book is a compendium of the most current research on itch, its prevalence in society, and the problems associated with treatment. |
| bepotastine besilate ophthalmic solution: Ophthalmic Product Development Seshadri Neervannan, Uday B. Kompella, 2022-03-11 This is a comprehensive textbook addressing the unique aspects of drug development for ophthalmic use. Beginning with a perspective on anatomy and physiology of the eye, the book provides a critical appraisal of principles that underlie ocular drug product development. The coverage encompasses topical and intraocular formulations, small molecules and biologics (including protein and gene therapies), conventional formulations (including solutions, suspensions, and emulsions), novel formulations (including nanoparticles, microparticles, and hydrogels), devices, and specialty products. Critical elements such as pharmacokinetics, influence of formulation technologies and ingredients, as well as impact of disease conditions on products development are addressed. Products intended for both the front and the back of the eye are discussed with an eye towards future advances. @font-face {font-family:Cambria Math; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Times New Roman,serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:Calibri,sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Times New Roman; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} |
| bepotastine besilate ophthalmic solution: Plumb's Veterinary Drug Handbook Donald C. Plumb, 2018-02-21 Plumb’s Veterinary Drug Handbook, Ninth Edition updates the most complete, detailed, and trusted source of drug information relevant to veterinary medicine. Provides a fully updated edition of the classic veterinary drug handbook, with carefully curated dosages per indication for clear guidance on selecting a dose Features 16 new drugs Offers an authoritative, complete reference for detailed information about animal medication Designed to be used every day in the fast-paced veterinary setting Includes dosages for a wide range of species, including dogs, cats, exotic animals, and farm animals |
| bepotastine besilate ophthalmic solution: Side Effects of Drugs Annual Jeffrey K Aronson, 2014-03-04 The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading. - Provides a critical yearly survey of new data and trends - Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors |
| bepotastine besilate ophthalmic solution: Angle Closure and Angle Closure Glaucoma Robert N. Weinreb, David S. Friedman, 2006 This is the third glaucoma consensus held under the auspices of the AIGS. It is anticipated that the discussions and conclusions from this consensus will impact care of patients with Angle Closure and Angle Closure Glaucoma significantly. As with the previous consensus meetings on Glaucoma Diagnosis and Open Angle Glaucoma Surgery, the consensus reports were developed over several months in an interactive internet system. The Consensus faculty, consisting of leading authorities on Angle Closure from throughout the world, met in Fort Lauderdale on May 3, 2006 to discuss the reports and refine t. |
| bepotastine besilate ophthalmic solution: Ocular Allergy Leonard Bielory, 2008 Topics include: Introduction- Immunopathophysiology and Classification of Ocular Allergy, OcularMast CDermatologicdisorders of the Eyelidsells and Mediators,SeasonalAllergic Conjunctivitis&Perennial Allergic Conjunctivitis,VernalKeratoconjunctivitis,GiantPapillary Conjunctivitis,Dermatologicdisorders of the Eyelids,ContactDermatitis of the Eyelids,AutoimmuneDisorders of the Anterior Surface,PediatricConcerns of Ocular Inflammation,ContactLens,OcularAllergy Treatment,Adverse(Allergic) Effects of GlaucomaMedications |
| bepotastine besilate ophthalmic solution: Frontiers in Clinical Drug Research - Anti-Allergy Agents Atta-ur-Rahman, 2018-07-11 Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field. |
| bepotastine besilate ophthalmic solution: Ocular Surface Disorders Jose M Benitez-del-Castillo, Michael A Lemp, 2013-11-04 Current knowledge of the epidemiology, clinical expression, pathophysiology and available medical and surgical therapy for ocular surface diseases, providing an invaluable text for ocular surface specialists, general ophthalmologists, optometrists and residents. |
| bepotastine besilate ophthalmic solution: Recent Developments in Anti-Inflammatory Therapy Parteek Prasher, Flavia Zacconi, Kamal Dua, Michael Rathbone, Jeffrey Withey, 2023-02-17 Advances in Anti-inflammatory Therapy explores the cutting-edge in anti-inflammation therapy in clear and concise language, with insights from academia and industry. Sections cover key regulatory pathways that mediate acute and chronic inflammation and disease onset. Further chapters are devoted to advanced anti-inflammatory pharmaceuticals, including chemical moieties, pharmacophores, APIs, natural products, herbal therapies, molecular nanomedicine and advanced drug delivery vectors. Systematically planned chapters and illustrations enable potential readers to gain essential insights on the most recent advancements in the field. Arranged with systematic chapters covering a broad range of inflammatory diseases, discussions on past, current and future therapeutics and advanced anti-inflammatory pharmaceuticals, this book will be useful to a wide range of researchers, especially medicinal chemists, drug design experts, and biological and translational researchers working in the field of inflammation. - Identifies recent developments and current trends in anti-inflammation therapy - Discusses advanced chemotherapeutics, SAR analysis of novel pharmacophores and natural products - Outlines the pathophysiology of inflammatory pathways in the pathogenesis of disease onset, including strategies to counter these intricacies - Contains a blend of editors from both academia and industry |
| bepotastine besilate ophthalmic solution: Nano-Biomaterials For Ophthalmic Drug Delivery Yashwant Pathak, Vijaykumar Sutariya, Anjali A. Hirani, 2016-11-12 This consolidated reference book addresses the various aspects of nano biomaterials used in ophthalmic drug delivery, including their characterization, interactions with ophthalmic system and applications in treatments of the ophthalmic diseases and disorders. In the last decade, a significant growth in polymer sciences, nanotechnology and biotechnology has resulted in the development of new nano- and bioengineered nano-bio-materials. These are extensively explored as drug delivery carriers as well as for implantable devices and scaffolds. At the interface between nanomaterials and biological systems, the organic and synthetic worlds merge into a new science concerned with the safe use of nanotechnology and nano material design for biological applications. For this field to evolve, there is a need to understand the dynamic forces and molecular components that shape these interactions. While it is impossible to describe with certainty all the bio physicochemical interactions at play at the interface, we are at a point where the pockets of assembled knowledge are providing a conceptual framework to guide this exploration, and review the impact on future product development. The book is intended as a valuable resource for academics and pharmaceutical scientists working in the field of polymers, polymers materials for drug delivery, drug delivery systems and ophthalmic drug delivery systems, in addition to medical and health care professionals in these areas. |
| bepotastine besilate ophthalmic solution: Pharmacologic Therapy of Ocular Disease Scott M. Whitcup, Dimitri T. Azar, 2017-06-05 There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function. |
| bepotastine besilate ophthalmic solution: Litt's Drug Eruptions & Reactions Manual Neil Shear, 2011-01-15 Litt's Drug Eruptions and Reactions Manual (D.E.R.M.), is a guide to drug eruptions, adverse reactions and clinically relevant drug-drug interactions associated with over 1300 drugs. This simple, well-organised book systematically catalogues adverse reactions and cutaneous side-effects of drugs that are used to treat dozens of conditions.Internatio |
| bepotastine besilate ophthalmic solution: Plumb's Veterinary Drug Handbook James A. Budde, Dawn M. McCluskey, 2023-05-31 Plumb’sTM VETERINARY DRUG HANDBOOK Find drug dosages and other critical information for prescribing drugs to animals quickly and efficiently in this fully updated new edition of this must-have veterinary resource The Tenth Edition of Plumb’s® Veterinary Drug Handbook updates the most comprehensive, detailed, and trusted source of drug information relevant to veterinary medicine. Covering dosages, drug interactions, adverse effects, and contraindications, among other key drug details, this bestselling book is a must for practicing veterinarians and anyone requiring reliable information on the use of drugs in animals. Designed for ease of use, the book surveys an exhaustive list of drugs with applications for a wide variety of species, including dogs, cats, birds, small mammals, and farm animals. This edition includes updates to all 738 drug monographs and adds 30 new monographs, including 9 new insulin monographs, to its exhaustive coverage of drugs used in the care of animals. This new edition: Provides an extensively reviewed and updated version of the must-have veterinary drug reference Includes 30 new drug monographs, including 9 new insulin monographs Updates all 738 drug monographs, with robust citing of new information Covers a wide variety of species, including dogs, cats, birds, small mammals, and farm animals Presents detailed dosing information for an exhaustive list of drugs used in animals Plumb’s® exhaustive coverage of drugs relevant to the veterinary field makes this book an essential reference for veterinarians, veterinary technicians, veterinary pharmacologists, pharmacists with veterinary patients, and libraries that serve these groups. |
| bepotastine besilate ophthalmic solution: Allergic and Immunologic Diseases Christopher Chang, 2022-10-14 **Selected for Doody's Core Titles® 2024 in Allergy/Clinical Immunology** Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic Diseases is a valuable resource for researchers and others involved in the day-to-day practice of allergy and immunology, with specific information, protocols and algorithms to guide their thinking. The book provides practical information and an explanation of why and how we do things, while also addressing the limitations of testing and treatment. Other sections focus on scientific based practices and the known pathophysiology of allergic and immunologic diseases, along with mechanisms of action in various treatment modalities. This book is unique in that it explains the rationale behind everything we do in allergy and immunology, hence it offers readers specific information on procedures and how to order tests and treat allergic and immunologic diseases. - Contains useful information on allergic and immunologic diseases, from why we do things the way we do, to methodologies, interpretation of the results and management of diseases - Provides information that can be immediately downloadable for any specific procedure or treatment algorithm for immediate use - Evaluates scientific merit and evidence or lack thereof |
| bepotastine besilate ophthalmic solution: Visual Field Studies Ralph Irving Lloyd, 1926 |
| bepotastine besilate ophthalmic solution: Drugs for Pregnant and Lactating Women E-Book Carl P. Weiner, 2018-10-17 Logically organized and easy to use, Drugs for Pregnant and Lactating Women, 3rd Edition, is your #1 resource for details on how virtually all of today's drugs and herbal supplements interact with pregnancy and lactation. More than just a dosing manual, this unique title by Dr. Carl P. Weiner fully explains whether each drug is FDA-approved for use by expecting or nursing mothers, is known to be safe for use, or is known to pose a danger. With up-to-date coverage of nearly 2,000 substances, it provides the thorough details you need to choose the most effective course of treatment. - Uses a consistent, easy-to-follow format for each substance: generic and trade name • class • indications • mechanism of action • dosage, with contraindications and cautions • maternal considerations • fetal considerations • drug interactions • breastfeeding safety • references • and summary information. - Describes over-the-counter drugs and alternative medications as well as prescription drugs. - Uses an eye-catching icon to highlight known teratogens. - Includes international drug names to give this reference a global perspective. - Features new letter thumb tabs for easier navigation. - Includes dozens of new drugs and thorough updates throughout. - Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, images, videos (including video updates), glossary, and references from the book on a variety of devices. |
| bepotastine besilate ophthalmic solution: The APRN and PA's Complete Guide to Prescribing Drug Therapy 2024 Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE, 2024-02-15 An unrivaled reference tool for advanced practice providers and students in clinical practice settings This concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice. The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. New to this Edition: Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases. Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma. Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populations Key Features: Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations. Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions. Serves advanced practice providers across the United States and internationally. Consistent with approvals and recommendations for use by the FDA. |
| bepotastine besilate ophthalmic solution: Itch E. Carstens, Tasuku Akiyama, 2014-02-25 Advances in itch research have elucidated differences between itch and pain but have also blurred the distinction between them. There is a long debate about how somatic sensations including touch, pain, itch, and temperature sensitivity are encoded by the nervous system. Research suggests that each sensory modality is processed along a fixed, direc |
| bepotastine besilate ophthalmic solution: The APRN and PA’s Complete Guide to Prescribing Drug Therapy 2022 Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE, 2021-07-06 Includes 25 new diagnoses and digital updates as needed! The only prescribing guide conveniently organized by clinical diagnoses for adult and pediatric patients, this concise resource is an unrivaled reference tool for advanced health care providers (AHCPs) and students in all clinical practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Newly updated for 2022 with the most recent drug information and clinical guidance, this revised edition contains 25 new diagnoses including 15 additional cancer diagnoses and the novel Coronavirus (COVID-19). The APRN and PA's Complete Guide to Prescribing Drug Therapy 2022 intersperses clinically useful information throughout, such as monitored laboratory values, patient teaching points, and safety information. Section I alphabetically presents pharmacotherapy regimens for more than 600 clinical diagnoses. Each diagnosis contains drug choices alphabetically by generic name, FDA pregnancy category, OTC availability, generic availability, adult and pediatric dosing regimens, brand/trade names, available dose forms, and additive information. Section II uses a convenient table format to convey pediatric and adult immunization schedules, contraceptives, pediatric dosing tables for liquid anti infectives, and much more. An alphabetical cross reference index of drugs by generic and brand/trade names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and relative safety during pregnancy. Key Features: Uniquely organized by clinical diagnosis! Addresses drug treatment options for over 600 specific diagnoses Guides the AHCP through drug classes, categories, and brand/trade names for primary care health issues Contains over 30 Appendices with quick access to drugs by category (e.g., antineoplastics, anticonvulsants), child and adult immunization schedules, contraceptives by form, glucocorticosteroids by potency, and much more! Index provides cross referencing of drugs by generic and brand/trade names Includes eBook and regular updates with purchase of print guide |
| bepotastine besilate ophthalmic solution: Pharmaceutical Calculations Mitchell J. Stoklosa, Howard C. Ansel, 1986 |
| bepotastine besilate ophthalmic solution: Pharmacology of Itch Alan Cowan, Gil Yosipovitch, 2015-04-10 Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios. |
| bepotastine besilate ophthalmic solution: Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, 2014-05-23 These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject. |
| bepotastine besilate ophthalmic solution: The Medical Letter on Drugs and Therapeutics , 2010 |
| bepotastine besilate ophthalmic solution: The APRN and PA’s Complete Guide to Prescribing Drug Therapy 2020 Mari J. Wirfs, PhD, MN, APRN, ANP-BC, FNP-BC, CNE, 2019-05-09 Includes more than 30 new diagnoses and eBook with digital updates as needed! Updated to deliver the most current standards, this is a unique prescribing reference for APRN students and advanced health care providers in all practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Concise, easy to read, and updated throughout, the resource delivers pharmacotherapy regimens for more than 600 diagnoses—including over 30 that are new. The print format includes an eBook with digital updates to assure immediate access to essential information. Listed alphabetically by diagnosis, pharmacotherapy regimens include, for each diagnosis, drug choices listed by generic name, FDA pregnancy category, generic/over-the-counter availability, adult/pediatric dosing regimens, brand names, forms of dosage, and additives. Clinically useful information such as laboratory values to be monitored, patient teaching points, and safety information is interspersed throughout each diagnosis. Additional quick-access features include information presented in convenient table format and an alphabetical cross-reference index of drugs by generic and brand name, with FDA pregnancy category and controlled drug schedule (I, II, III, IV, V). Key Features: Includes 31 new diagnoses totaling over 600 organized alphabetically Serves as a quick-access prescribing reference for APRN and PA students and health care providers in all primary care settings Presents drug information in condensed and summary form for ease of use Within each diagnosis, drug choices are listed alphabetically by generic /trade name, FDA pregnancy category, adult/pediatric dosing, dose forms, and additives Delivers guidance on lab values to be monitored, patient education points, and safety information Includes 30 Appendices with ready access to key drug classifications, FDA Pregnancy Categories, US Schedule of Controlled Substances, Immunization Schedules, Contraceptive Guidance, categories Anti-Infectives, and more! Offers brand/generic cross-reference |
| bepotastine besilate ophthalmic solution: Stoklosa and Ansel's Pharmaceutical Calculations Shelly J. Stockton, 2021-03-22 The gold standard on pharmaceutical calculations, this widely acclaimed text covers the full range of calculations pharmacy students must learn for successful pharmacy practice, including dosing, compounding, metric conversions and more. Thoroughly reviewed by practitioners and educators and extensively revised and updated, this 16th edition maintains high standards for both academic and basic practice requirements while offering the most comprehensive and in-depth coverage of pharmacy calculations available. A consistent, step-by-step approach makes it easy to work through the problems and gain a greater understanding of the underlying concepts, and new online access to calculation problems makes this the most engaging edition yet. |
| bepotastine besilate ophthalmic solution: The Massachusetts Eye and Ear Infirmary Illustrated Manual of Ophthalmology Neil J. Friedman, Peter K. Kaiser, Roberto Pineda, II, 2009-01-01 With high quality color images combined with up-to-date treatment guidelines and a proven template, the third edition of The Massachusetts Eye and Ear Infirmary Illustrated Manual of Ophthalmology is a vital companion for every ophthalmic trainee, primary care practitioner and emergency trauma unit. The bonus PDA software allows you to access the entire contents of the manual on the go. Provides thorough, easily accessible and up-to-date information for all common eye disorders, creating an all-in-one resource for quick diagnosis and treatment. Uses highlighted emergency management boxes for a clear presentation of the crucial treatment of critical situations. Follows a templated format with key boxes highlighting important information. Presents full-color photographs throughout so you can compare real case presentations for more accurate diagnosis. Orders chapters anatomically (not by ophthalmic subspecialty) making it easier to locate the desired information by looking at the effected area. Provides a complete and thorough update with expanded sections, including age related macular degeneration, diabetic retinopathy, uveitis, glaucoma, dry eye, and refractive surgeries. Incorporates over 100 new high quality clinical color photos plus spectral domain OCT, CT scan, fluorescein angiogram, visual field, and corneal topography images. Adds brand new appendices outlining basic eye care and differential diagnosis information to help minimize wasted time in the clinic. Offers immediate and convenient access to the whole manual when on the go with bonus PDA software. |
| bepotastine besilate ophthalmic solution: Roy and Fraunfelder's Current Ocular Therapy Frederick Hampton Roy, Frederick W. Fraunfelder, Frederick T. Fraunfelder, 2008-01-01 This book is designed to be concise with a consistent format so that the clinician can focus on a specific area. This edition has had major modifications and embraces evidence-based medicine. The format includes the CPT codes for billing purposes, short description of the condition, etiology/incidence, course/prognosis, laboratory findings, differential diagnosis; prophylaxis, treatment (local and systemic, surgical or other), miscellaneous (names and addresses of support groups) and key references. Incorporates evidence-based medicine so you feel confident that you're formulating the best treatment plans for your patients.Color photos allow you to read about and actually see a picture of select disease entities.Clear, concise format can be photocopied and distributed to patients in some cases, reducing your time spent explaining problems to patients and caregivers. |
| bepotastine besilate ophthalmic solution: Textbook of Allergy for the Clinician Pudupakkam K. Vedanthan, Harold S. Nelson, Shripad N. Agashe, Mahesh P A, Rohit Katial, 2016-04-19 This well-illustrated book synthesizes all aspects of allergy, asthma, and related fields such as aerobiology and immunology. Appropriate for allergy practitioners and medical students seeking the latest information on allergy and asthma, it covers aeroallergens and their source plants all over the world.The book focuses on allergies caus |
| bepotastine besilate ophthalmic solution: Allergy and Asthma , 2019-06-25 Allergy and Asthma: The Basics to Best Practices is intended to serve as a single comprehensive reference covering all needed knowledge of allergic diseases. Allergy is a unique and distinctive area of medicine wherein learning the fundamentals requires gathering information from various different disciplines. Allergic diseases affect various organ systems and the practice of a wide range of physicians from otolaryngologists, and pulmonologists, to gastroenterologists, dermatologists, and ophthalmologists. Clinicians and trainees alike will benefit from a resource that introduces the basic concepts, as well as providing comprehensive, consistently up-to-date instruction on intermediate and advanced conditions, research, and treatment strategies. The book is divided into nine sections and is written by some of the foremost experts in the field. Allergy and Asthma opens with an introduction which covers the epidemiology of allergic diseases, fundamentals of allergy and immunology, and a thorough grounding of different types of allergens. Early sections address allergic upper airway diseases, allergic skin diseases, and asthma in detail, using a structured, consistent format from chapter to chapter to provide continuity and ease of reference. Later sections thoroughly cover various food allergies, insect allergies, drug allergy, anaphylaxis, and utilize ample tables and illustrations to provide additional learning tools for the reader. This major reference not only provides basic knowledge on diagnosing and treating allergies, but moves beyond these basics to emphasize using a systematic approach to working up and treating a patient. A variety of techniques used in diagnosing asthma and allergy will be examined, of which include prick skin tests, in-vitro testing, patch testing and non-conventional allergy tests. Concluding this book are sections dedicated to management, therapeutic strategies of allergy and asthma, with a look to future research directions for this unique field. Physicians and residents in allergy and immunology, pulmonology, otolaryngology, gastroenterology, dermatology, ophthalmology and other specialties will find the work of value in enhancing their practice and studies. Researchers in a range of areas especially immunology and food science will also find this text to be a compelling and reliable resource. |
| bepotastine besilate ophthalmic solution: Nursing2019 Drug Handbook Lippincott, 2013-02-12 THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features Completely updated nursing-focused drug monographs featuring over 3,650 generic, brand-name, and combination drugs in an easy A-to-Z format 37 brand-new FDA-approved drugs in this edition, including 33 complete monographs—tabbed and conveniently grouped in a handy “new drugs” section for easy retrieval More than 8,000 clinical updates—new dosages and indications, Black Box warnings, adverse reactions, nursing considerations, clinical alerts, and patient teaching information NEW logos highlighting biosimilar drugs and drugs with genetic-related considerations NEW appendix—Ophthalmic drugs: Indications and dosages Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 462 commonly prescribed tablets and capsules Plus FREE companion Toolkit available online through NDHnow.com Monthly FDA updates featuring newly approved drugs, indications, and warnings Pharmacology videos, audio pronunciation guide, and English-Spanish translator Equianalgesic dosing guidelines for opioid drugs Mechanisms and sites of action graphics for selected drugs NCLEX®-style questions, free CE tests, plus bonus discounts...and more! |
| bepotastine besilate ophthalmic solution: Nursing 2025-2026 Drug Handbook Lippincott Williams Wilkins, 2024-03-15 The #1 Drug Guide for nurses and clinicians . . . always dependable, always up to-date! Now in its 45th Edition, Nursing2025-2026 Drug Handbook delivers the most current nursing focused information on more than 3,600 generic, brand-name, and combination drugs in an easy-to-use A-Z format. Features → NEW! Includes 24 brand-new FDA-approved drugs—tabbed and conveniently grouped in a handy “NEW DRUGS” section for easy retrieval → NEW! Thousands of clinical updates—new dosages and indications, FDA boxed warnings, genetic-related information, adverse reactions, interactions, nursing considerations, clinical alerts, and patient teaching information → Special focus on U.S. and Canadian drug safety issues and concerns → Plus FREE access to these additional resources available on Lippincott NursingCenter® at https://www.nursingcenter.com: Monthly FDA updates and news Newly approved drugs New indications and dosages Drug warnings Drug news abstracts Medication safety information Types of medication errors, including causes and common errors Preventing and reducing medication errors Reporting medication errors Real-life stories of medication errors |
| bepotastine besilate ophthalmic solution: Pruritus Medicine Sonja Ständer, Martin Schmelz, Yan-Gang Sun, 2021-11-24 |
| bepotastine besilate ophthalmic solution: Nursing2015 Drug Handbook Lippincott, 2014 As in previous editions, this handbook emphasizes nursing and safety aspects of drug administration without attempting to replace detailed pharmacology texts. Only the most essential information is included, and helpful grpahic symbols, logos, and highligting draw special attention to critical details that can't be overlooked.--page v. |
| bepotastine besilate ophthalmic solution: Ophthalmology Explorer Dhaval Patel, 2014-01-07 This is ophthalmology PG Exam preparation manual I have prepared during my residency and added up while preparing for senior residency/ fellowship examinations which may serve as a small guide to your exams. It will also serve as a good collection of facts which we might forget/neglect during overall MD/MS exam preparation. |
Bepotastine: Indications, Side Effects, Warnings - Drugs.com
Bepotastine. Generic name: Bepotastine [ be-poe-TAS-teen ] Brand name: Bepreve Drug class: Ophthalmic antihistamines and decongestants. …
Bepotastine - Wikipedia
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. [2] It was approved in Japan for use in the treatment of allergic rhinitis and …
Bepreve (Bepotastine): Uses, Side Effects, Dosage & More
Apr 4, 2025 · Bepotastine (Bepreve) is an allergy eye drop for people over the age of 2. It's an antihistamine medication that helps with itchy eyes …
Bepotastine (Bepreve) - Uses, Side Effects, and More
Dec 4, 2024 · Overview: Bepotastine is an eye drop used to treat itchy eyes caused by allergies. The most common side effects are eye irritation, …
Bepotastine besilate (ophthalmic route) - Mayo C…
Feb 1, 2025 · Bepotastine besilate eye drops is used to treat itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing …
Bepotastine: Indications, Side Effects, Warnings - Drugs.com
Bepotastine. Generic name: Bepotastine [ be-poe-TAS-teen ] Brand name: Bepreve Drug class: Ophthalmic antihistamines and decongestants. Uses; Before taking; Warnings; Dosage; Side …
Bepotastine - Wikipedia
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. [2] It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000, and January 2002, …
Bepreve (Bepotastine): Uses, Side Effects, Dosage & More - GoodRx
Apr 4, 2025 · Bepotastine (Bepreve) is an allergy eye drop for people over the age of 2. It's an antihistamine medication that helps with itchy eyes from allergies. The typical dosing is to put …
Bepotastine (Bepreve) - Uses, Side Effects, and More
Dec 4, 2024 · Overview: Bepotastine is an eye drop used to treat itchy eyes caused by allergies. The most common side effects are eye irritation, headache, infection in the nose or throat, or …
Bepotastine besilate (ophthalmic route) - Mayo Clinic
Feb 1, 2025 · Bepotastine besilate eye drops is used to treat itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the effects of certain …
Bepotastine: Uses, Interactions, Mechanism of Action ...
Oct 21, 2007 · Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. It belongs to the second-generation piperidine chemical class. It is a mast cell …
Bepreve (bepotastine) dosing, indications, interactions ...
Medscape - Indication-specific dosing for Bepreve (bepotastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …
